Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Convertible Debt: 2009-2013

Historic Convertible Debt for UNITED THERAPEUTICS (UTHR) over the last 1 years, with Mar 2013 value amounting to $207.4 million.

  • UNITED THERAPEUTICS's Convertible Debt rose 5.41% to $207.4 million in Q1 2013 from the same period last year, while for Mar 2013 it was $207.4 million, marking a year-over-year increase of 5.41%. This contributed to the annual value of $204.7 million for FY2012, which is 5.40% up from last year.
  • As of Q1 2013, UNITED THERAPEUTICS's Convertible Debt stood at $207.4 million, which was up 1.33% from $204.7 million recorded in Q4 2012.
  • UNITED THERAPEUTICS's 5-year Convertible Debt high stood at $207.4 million for Q1 2013, and its period low was $1.2 million during Q3 2009.
  • Moreover, its 3-year median value for Convertible Debt was $200.7 million (2012), whereas its average is $200.7 million.
  • Data for UNITED THERAPEUTICS's Convertible Debt shows a peak YoY grew of 5.41% (in 2013) over the last 5 years.
  • Quarterly analysis of 4 years shows UNITED THERAPEUTICS's Convertible Debt stood at $1.2 million in 2009, then reached $194.2 million in 2011, then rose by 5.40% to $204.7 million in 2012, then rose by 5.41% to $207.4 million in 2013.
  • Its last three reported values are $207.4 million in Q1 2013, $204.7 million for Q4 2012, and $202.0 million during Q3 2012.